Ratings by Chardan (Keay Nakae)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/10/2026 | CAMP4 Therapeutics Corp | CAMP | New Coverage | Buy (N/A) |
4.09 (4.44) |
8.56% | Details | |
| 3/12/2026 | Orchestra BioMed Inc. | OBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Allurion Technologies | ALUR | Upgrade | Buy (Neutral) |
1.75 (0.58) |
-66.86% | Details | |
| 1/29/2026 | Korro Bio Inc. | KRRO | Upgrade | Buy (Neutral) |
10.74 (14.05) |
30.82% | Details | |
| 1/5/2026 | Stoke Therapeutics | STOK | New Coverage | Buy (N/A) |
31.74 (31.73) |
-0.03% | Details | |
| 1/5/2026 | Reviva Pharmaceuticals | RVPH | New Coverage | Buy (N/A) |
0.28 (0.35) |
25% | Details | |
| 1/5/2026 | Alto Neuroscience | ANRO | New Coverage | Buy (N/A) |
17.80 (25.42) |
42.81% | Details | |
| 11/13/2025 | Korro Bio Inc. | KRRO | Downgrade | Neutral (Buy) |
32.80 (10.74) |
-67.26% | Details | |
| 11/10/2025 | Monopar Therapeutics | MNPR | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Avidity Biosciences | RNA | Downgrade | Neutral (Buy) |
69.80 (12.91) |
-81.5% | Details | |
| 10/28/2025 | Avidity Biosciences | RNA | Downgrade | Neutral (Buy) |
49.15 (69.80) |
42.01% | Details | |
| 8/8/2025 | SAB Biotherapeutics | SABS | Maintain | Buy (N/A) |
|
Details | ||
| 6/25/2025 | iBio, Inc. | IBIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/23/2025 | Monopar Therapeutics | MNPR | New Coverage | Buy (N/A) |
32.86 (84.94) |
158.49% | Details | |
| 6/17/2025 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2025 | Seres Therapeutics | MCRB | Downgrade | Neutral (Buy) |
8.29 (7.16) |
-13.63% | Details | |
| 4/16/2025 | Korro Bio Inc. | KRRO | New Coverage | Buy (N/A) |
12.84 (32.80) |
155.45% | Details | |
| 3/27/2025 | Allurion Technologies | ALUR | Maintain | Neutral (N/A) |
|
Details | ||
| 3/17/2025 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2024 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2024 | Allurion Technologies | ALUR | Downgrade | Neutral (Buy) |
0.52 (1.75) |
236.54% | Details | |
| 8/22/2024 | Allurion Technologies | ALUR | Maintain | Buy (N/A) |
|
Details | ||
| 5/28/2024 | iBio, Inc. | IBIO | New Coverage | Buy (N/A) |
2.19 (1.68) |
-23.29% | Details | |
| 4/4/2024 | Allurion Technologies | ALUR | New Coverage | Buy (N/A) |
1.73 (0.52) |
-69.94% | Details | |
| 4/1/2024 | Omega Therapeutics | OMGA | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2024 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2024 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2024 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2023 | Notable Labs, Inc. | NTBL | New Coverage | Buy (N/A) |
3.27 (0.25) |
-92.35% | Details | |
| 11/8/2023 | ProQR Therapeutics N.V. | PRQR | Upgrade | Buy (Neutral) |
1.22 (1.92) |
57.38% | Details | |
| 8/4/2023 | Mesoblast Limited | MESO | Maintain | Sell (N/A) |
|
Details | ||
| 5/30/2023 | Mesoblast Limited | MESO | Maintain | Sell (N/A) |
|
Details | ||
| 5/15/2023 | Gain Therapeutics | GANX | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Pear Therapeutics | PEAR | Downgrade | Neutral (Buy) |
0.39 (0.03) |
-92.31% | Details | |
| 3/3/2023 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Ocugen, Inc. | OCGN | Upgrade | Buy (Neutral) |
1.00 (1.40) |
40% | Details | |
| 2/7/2023 | Orchestra BioMed Inc. | OBIO | New Coverage | Buy (N/A) |
8.72 (4.04) |
-53.67% | Details | |
| 1/26/2023 | Coya Therapeutics | COYA | New Coverage | Buy (N/A) |
4.78 (5.42) |
13.39% | Details | |
| 12/9/2022 | Gain Therapeutics | GANX | New Coverage | Buy (N/A) |
3.21 (1.85) |
-42.37% | Details | |
| 11/16/2022 | Evelo Biosciences Inc | EVLO | Downgrade | Neutral (Buy) |
2.19 (0.00) |
-100% | Details | |
| 10/17/2022 | NeuBase Therapeutics | NBSE | Downgrade | Neutral (Buy) |
0.27 (0.38) |
40.74% | Details | |
| 9/23/2022 | Omega Therapeutics | OMGA | New Coverage | Buy (N/A) |
6.03 (0.14) |
-97.68% | Details | |
| 8/15/2022 | Evelo Biosciences Inc | EVLO | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2022 | Pear Therapeutics | PEAR | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2022 | ProQR Therapeutics N.V. | PRQR | Downgrade | Neutral (Buy) |
0.84 (1.92) |
128.57% | Details | |
| 7/20/2022 | Dyne Therapeutics | DYN | New Coverage | Buy (N/A) |
10.25 (20.73) |
102.24% | Details | |
| 7/20/2022 | Avidity Biosciences | RNA | New Coverage | Buy (N/A) |
17.76 (49.15) |
176.75% | Details | |
| 5/13/2022 | SAB Biotherapeutics | SABS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2022 | NeuBase Therapeutics | NBSE | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2022 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2022 | Kaleido Biosciences Inc. | KLDO | Downgrade | Neutral (Buy) |
1.70 (0.00) |
-100% | Details | |
| 3/31/2022 | Silence Therapeutics | SLN | New Coverage | Buy (N/A) |
19.48 (7.51) |
-61.45% | Details | |
| 1/31/2022 | Kaleido Biosciences Inc. | KLDO | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2021 | Pear Therapeutics | PEAR | New Coverage | Buy (N/A) |
7.14 (0.03) |
-99.58% | Details | |
| 12/20/2021 | Sonnet BioTherapeutics | SONN | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2021 | Exicure | XCUR | Downgrade | Neutral (Buy) |
0.46 (2.95) |
541.3% | Details | |
| 12/9/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Neutral (Buy) |
38.16 (38.22) |
0.16% | Details | |
| 11/12/2021 | Kaleido Biosciences Inc. | KLDO | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2021 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | SAB Biotherapeutics | SABS | New Coverage | Buy (N/A) |
8.07 (4.04) |
-49.94% | Details | |
| 11/1/2021 | Evelo Biosciences Inc | EVLO | Upgrade | Buy (Neutral) |
8.85 (0.00) |
-100% | Details | |
| 10/19/2021 | BiomX | PHGE | Maintain | Buy (N/A) |
|
Details | ||
| 8/31/2021 | Mesoblast Limited | MESO | Maintain | Sell (N/A) |
|
Details | ||
| 8/9/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Arrowhead Pharma | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2021 | Evelo Biosciences Inc | EVLO | Maintain | Neutral (N/A) |
|
Details | ||
| 7/23/2021 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2021 | Femasys Inc. | FEMY | New Coverage | Buy (N/A) |
7.41 (3.96) |
-46.56% | Details | |
| 6/10/2021 | Ocugen, Inc. | OCGN | Maintain | Neutral (N/A) |
|
Details | ||
| 6/3/2021 | Axcella Health Inc. | AXLA | New Coverage | Buy (N/A) |
3.33 (4.58) |
37.54% | Details | |
| 3/16/2021 | ContraFect Corp. | CFRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2021 | Emergent BioSolutions | EBS | Upgrade | Buy (Neutral) |
93.49 (8.33) |
-91.09% | Details | |
| 2/19/2021 | Emergent BioSolutions | EBS | Downgrade | Neutral (Buy) |
117.06 (93.49) |
-20.13% | Details | |
| 2/9/2021 | Ocugen, Inc. | OCGN | Downgrade | Neutral (Buy) |
15.81 (1.40) |
-91.14% | Details | |
| 1/25/2021 | La Jolla Pharma | LJPC | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | OncoCyte Corp | OCX | Downgrade | Neutral (Buy) |
3.23 (3.20) |
-0.93% | Details | |
| 6/8/2020 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Sonnet BioTherapeutics | SONN | New Coverage | Buy (N/A) |
3.99 (1.26) |
-68.42% | Details | |
| 5/1/2020 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2020 | NeuBase Therapeutics | NBSE | New Coverage | Buy (N/A) |
8.23 (0.38) |
-95.38% | Details | |
| 12/19/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2019 | Arrowhead Research | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 11/27/2019 | Ocugen, Inc. | OCGN | New Coverage | Buy (N/A) |
0.31 (15.81) |
5000% | Details | |
| 11/1/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2019 | Arrowhead Research | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 10/4/2019 | Arbutus Biopharma | ABUS | Downgrade | Neutral (Buy) |
1.43 (3.03) |
111.89% | Details | |
| 9/27/2019 | Chardan Healthcare Acquisition Corp. | CHAC | New Coverage | Buy (N/A) |
10.11 (9.72) |
-3.86% | Details | |
| 9/4/2019 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2019 | La Jolla Pharma | LJPC | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2019 | Arbutus Biopharma | ABUS | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2019 | Exicure | XCUR | New Coverage | Buy (N/A) |
2.25 (2.95) |
31.11% | Details | |
| 3/15/2019 | Caladrius Biosciences | CLBS | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2019 | ADMA Biologics | ADMA | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2019 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2019 | Dicerna Pharmaceuticals | DRNA | Upgrade | Buy (Neutral) |
10.77 (38.22) |
254.87% | Details | |
| 9/20/2018 | BioSig Technologies | BSGM | Maintain | Buy (N/A) |
|
Details | ||
| 9/6/2018 | Arrowhead Research | ARWR | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2018 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2018 | Emergent BioSolutions | EBS | Maintain | Buy (N/A) |
|
Details |
